{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:23:13Z","timestamp":1790468593358,"version":"4.1.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867"],"award-info":[{"award-number":["Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867"],"award-info":[{"award-number":["Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867"],"award-info":[{"award-number":["Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214180","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T13:24:02Z","timestamp":1565011442000},"page":"e0214180","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7388-6082","authenticated-orcid":true,"given":"Andrea V.","family":"Margulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hernandez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estel","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Almqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"D\u2019Onofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sara","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"issue":"10006","key":"ref1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(15)00045-8","article-title":"Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis","volume":"386","author":"L Viale","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"AA Veroniki","year":"2017","journal-title":"BMC Med"},{"issue":"17","key":"ref3","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1001\/jama.2017.14485","article-title":"Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children","volume":"318","author":"RL Bromley","year":"2017","journal-title":"JAMA"},{"key":"ref4","first-page":"CD010224","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"11","author":"J Weston","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"T Tomson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40272-018-0294-0","article-title":"Dose-Dependent Teratology in Humans: Clinical Implications for Prevention","volume":"20","author":"G Koren","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40801-016-0078-1","article-title":"The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review","volume":"3","author":"J de Jong","year":"2016","journal-title":"Drugs Real World Outcomes"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-0035-1556741","article-title":"An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes","volume":"4","author":"EE Gerard","year":"2015","journal-title":"J Pediatr Genet"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"e017248","DOI":"10.1136\/bmjopen-2017-017248","article-title":"Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis","volume":"7","author":"AA Veroniki","year":"2017","journal-title":"BMJ Open"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.seizure.2016.10.006","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes","volume":"44","author":"RL Bromley","year":"2017","journal-title":"Seizure"},{"key":"ref11","unstructured":"Raguideau F, Zureik M, Dray-Spira R, Bloti\u00e8re P-O, Weill A, Coste J. Exposition in utero \u00e0 l\u2019acide valpro\u00efque et aux autres traitements de l\u2019\u00e9pilepsie et des troubles bipolaires et risque de malformations cong\u00e9nitales majeures (MCM) en France. France2017 [cited 2 August 2018]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/fb3faa8c4a5c5c5dedfc1423213c219d.pdf\" xlink:type=\"simple\">https:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/fb3faa8c4a5c5c5dedfc1423213c219d.pdf<\/ext-link>."},{"issue":"Suppl 2","key":"ref12","first-page":"408","article-title":"Antiepileptic drugs in pregnancy: searching for a reference drug for comparative safety","volume":"26","author":"AV Margulis","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.seizure.2009.09.002","article-title":"Population-based study of antiepileptic drug exposure in utero\u2014influence on head circumference in newborns","volume":"18","author":"M Almgren","year":"2009","journal-title":"Seizure"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40264-013-0052-8","article-title":"Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland","volume":"36","author":"M Artama","year":"2013","journal-title":"Drug Saf"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-1211(99)00020-0","article-title":"Intrauterine growth in the offspring of epileptic women: a prospective multicenter study","volume":"36","author":"D Battino","year":"1999","journal-title":"Epilepsy Res"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.25031","article-title":"Fetal growth and premature delivery in pregnant women on antiepileptic drugs","volume":"82","author":"S Hernandez-Diaz","year":"2017","journal-title":"Ann Neurol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0000000000000018","article-title":"Association between topiramate and zonisamide use during pregnancy and low birth weight","volume":"123","author":"S Hernandez-Diaz","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"8239","key":"ref18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(81)90354-8","article-title":"Fetal head growth retardation associated with maternal antiepileptic drugs","volume":"2","author":"VK Hiilesmaa","year":"1981","journal-title":"Lancet"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1471-0528.2000.tb11089.x","article-title":"Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight","volume":"107","author":"CL Hvas","year":"2000","journal-title":"BJOG"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/epi.12758","article-title":"Birth outcomes after prenatal exposure to antiepileptic drugs\u2014a population-based study","volume":"55","author":"D Kilic","year":"2014","journal-title":"Epilepsia"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/epi.13573","article-title":"Overweight in epilepsy as a risk factor for pregnancy and delivery complications","volume":"57","author":"E Kolstad","year":"2016","journal-title":"Epilepsia"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yebeh.2012.05.010","article-title":"Differential effects of antiepileptic drugs on neonatal outcomes","volume":"24","author":"PB Pennell","year":"2012","journal-title":"Epilepsy Behav"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1528-1167.2009.02147.x","article-title":"Pregnancy, delivery, and outcome for the child in maternal epilepsy","volume":"50","author":"G Veiby","year":"2009","journal-title":"Epilepsia"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00415-013-7239-x","article-title":"Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy","volume":"261","author":"G Veiby","year":"2014","journal-title":"J Neurol"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12884-016-1190-7","article-title":"Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model","volume":"17","author":"X Wen","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1528-1157.2000.tb00253.x","article-title":"Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years","volume":"41","author":"K Wide","year":"2000","journal-title":"Epilepsia"},{"issue":"24","key":"ref27","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1212\/WNL.0000000000002767","article-title":"Pregnancy outcome following maternal exposure to pregabalin may call for concern","volume":"86","author":"U Winterfeld","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40263-017-0439-7","article-title":"Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis","volume":"31","author":"G Pariente","year":"2017","journal-title":"CNS Drugs"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40263-017-0433-0","article-title":"Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis","volume":"31","author":"G Pariente","year":"2017","journal-title":"CNS Drugs"},{"key":"ref30","unstructured":"K\u00e4ll\u00e9n B, K\u00e4ll\u00e9n K. The Swedish Medical Birth Register\u2014a summary of content and quality. 2003 [cited 5 June 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.socialstyrelsen.se\/Lists\/Artikelkatalog\/Attachments\/10655\/2003-112-3_20031123.pdf\" xlink:type=\"simple\">https:\/\/www.socialstyrelsen.se\/Lists\/Artikelkatalog\/Attachments\/10655\/2003-112-3_20031123.pdf<\/ext-link>."},{"key":"ref31","unstructured":"WHO Collaborating Center for Drug Statistics Methodology. Defined daily dose, definition and general considerations 2009. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/\" xlink:type=\"simple\">http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/<\/ext-link>. Cited 14 February 2016."},{"key":"ref32","unstructured":"Abrahamsson K. Swedish Register of Education. 2018 [cited 22 July 2018]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.jpi-dataproject.eu\/Home\/Database\/348?topicId=4\" xlink:type=\"simple\">http:\/\/www.jpi-dataproject.eu\/Home\/Database\/348?topicId=4<\/ext-link>."},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"JF Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"ref34","unstructured":"EMA. Public summary of opinion on orphan designation. Carbamazepine for the treatment of metaphyseal chondrodysplasia, Schmid type. 2016 [cited 26 May 2019]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ema.europa.eu\/en\/documents\/orphan-designation\/eu\/3\/16\/1746-public-summary-positive-opinion-orphan-designation-carbamazepine-treatment-metaphyseal_en.pdf\" xlink:type=\"simple\">https:\/\/www.ema.europa.eu\/en\/documents\/orphan-designation\/eu\/3\/16\/1746-public-summary-positive-opinion-orphan-designation-carbamazepine-treatment-metaphyseal_en.pdf<\/ext-link>."},{"key":"ref35","unstructured":"European Commission. Public Health\u2014Union Register of medicinal products\u2014Procedures for nationally authorised products for human use. 2019 [cited 26 May 2019]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/reg_hum_refer.htm\" xlink:type=\"simple\">http:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/reg_hum_refer.htm<\/ext-link>."},{"key":"ref36","unstructured":"EMA. Lamictal\u2014Summary of product characteristics. 2017 [cited 26 May 2019]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lyrica\" xlink:type=\"simple\">https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lyrica<\/ext-link>."},{"key":"ref37","unstructured":"EMA. Annex II\u2014Scientific conclusions and grounds for amendment of the summaries of product characteristics, labelling and package leaflet presented by the EMEA. 2008 [cited 26 May]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ema.europa.eu\/en\/documents\/referral\/lamictal-article-30-referral-annex-i-ii-iii_en.pdf\" xlink:type=\"simple\">https:\/\/www.ema.europa.eu\/en\/documents\/referral\/lamictal-article-30-referral-annex-i-ii-iii_en.pdf<\/ext-link>."},{"key":"ref38","unstructured":"Hagenfeldt K, Alton V, Axelsson O, Blennow M, Boj\u00f6 F, Bygdeman M, et al. Routine Ultrasound Examination During Pregnancy [in Swedish]. Stockholm, Sweden1998 [cited 22 July 2018]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.sbu.se\/en\/publications\/sbu-assesses\/routine-ultrasound-examination-during-pregnancy\/\" xlink:type=\"simple\">https:\/\/www.sbu.se\/en\/publications\/sbu-assesses\/routine-ultrasound-examination-during-pregnancy\/<\/ext-link>."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2431-8-8","article-title":"Continuous growth reference from 24th week of gestation to 24 months by gender","volume":"8","author":"A Niklasson","year":"2008","journal-title":"BMC Pediatr"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1651-2227.1996.tb14164.x","article-title":"Intrauterine growth curves based on ultrasonically estimated foetal weights","volume":"85","author":"K Marsal","year":"1996","journal-title":"Acta Paediatr"},{"key":"ref41","first-page":"140","article-title":"Quantile Regression","author":"L Hao","year":"2007"},{"key":"ref42","article-title":"Lubricant use during intercourse and time to pregnancy: a prospective cohort study","author":"KA McInerney","year":"2018","journal-title":"BJOG"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/aje\/kwj162","article-title":"Re: &quot;Easy SAS calculations for risk or prevalence ratios and differences&quot;","volume":"163","author":"MR Petersen","year":"2006","journal-title":"Am J Epidemiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-8-9","article-title":"A comparison of two methods for estimating prevalence ratios","volume":"8","author":"MR Petersen","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/jnnp-2017-316143corr1","article-title":"Correction: Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study","volume":"89","author":"B Mostacci","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/jnnp-2017-316143","article-title":"Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study","volume":"89","author":"B Mostacci","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"21","key":"ref47","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1212\/WNL.0000000000003959","article-title":"Pregabalin use early in pregnancy and the risk of major congenital malformations","volume":"88","author":"E Patorno","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/ane.12965","article-title":"Antiepileptic drug polytherapy in pregnant women with epilepsy","volume":"138","author":"FJE Vajda","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"23","key":"ref49","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"J Jentink","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1212\/WNL.0b013e3182a43e81","article-title":"Dose dependence of fetal malformations associated with valproate","volume":"81","author":"FJ Vajda","year":"2013","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijporl.2018.07.035","article-title":"In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database","volume":"113","author":"C Foch","year":"2018","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jamaneurol.2017.5035","article-title":"Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children","volume":"75","author":"LS Elkjaer","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref53","unstructured":"Pharmacovigilance Risk Assessment Committee. Procedure under Article 31 of Directive 2001\/83\/EC resulting from pharmacovigilance data: substances related to valproate. 2014 [cited 18 November 2018]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.ema.europa.eu\/documents\/referral\/valproate-related-substances-article-31-referral-prac-assessment-report_en.pdf\" xlink:type=\"simple\">https:\/\/www.ema.europa.eu\/documents\/referral\/valproate-related-substances-article-31-referral-prac-assessment-report_en.pdf<\/ext-link>."},{"issue":"Suppl 3","key":"ref54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1528-1167.2009.02042.x","article-title":"Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959\u20132009","volume":"50","author":"SD Shorvon","year":"2009","journal-title":"Epilepsia"},{"key":"ref55","unstructured":"Raguideau F, Ehrhardt C, Dray-Spira R, Zureik M, Bloti\u00e8re P-O, Weill A, et al. Exposition \u00e0 l\u2019acide valpro\u00efque et ses d\u00e9riv\u00e9s au cours de la grossesse en France de 2007 \u00e0 2014: une \u00e9tude observationnelle sur les donn\u00e9es du SNIIRAM. France2016 [cited 11 August 2018]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ansm.sante.fr\/afssaps\/content\/download\/91481\/1148883\/version\/1\/file\/Rapport_EtudeVPA_24.08-def.pdf\" xlink:type=\"simple\">https:\/\/ansm.sante.fr\/afssaps\/content\/download\/91481\/1148883\/version\/1\/file\/Rapport_EtudeVPA_24.08-def.pdf<\/ext-link>."},{"key":"ref56","unstructured":"EMA. New measures to avoid valproate exposure in pregnancy endorsed. 2018 [cited 11 August 2018]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Valproate_2017_31\/European_Commission_final_decision\/WC500250216.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Valproate_2017_31\/European_Commission_final_decision\/WC500250216.pdf<\/ext-link>."},{"key":"ref57","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"JF Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/EDE.0000000000000661","article-title":"Cohort Variation in Selection During Pregnancy and Risk of Selected Birth Defects Among Males","volume":"28","author":"TA Bruckner","year":"2017","journal-title":"Epidemiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:27:47Z","timestamp":1589023667000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214180"}},"subtitle":[],"editor":[{"given":"Umberto","family":"Simeoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214180","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/574269","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]}}}